Phase 1 15 trials
Phase 1
NCT07446101 Mar 2026 → Feb 2027 expected —
Eli Lilly and Company
Recruiting
No outcome recorded
Phase 1
NCT05069896 Oct 2021 → Jun 2022 —
Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT04607733 Nov 2020 → May 2021 —
Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT04548219 Sep 2020 → Jan 2021 —
Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT04137380 Dec 2019 → Dec 2020 —
Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT03886948 Mar → Oct 2019 —
Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT03718884 Oct 2018 → Oct 2019 psoriasis Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT03748940 Oct 2018 → Jun 2019 —
Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT03662100 Sep 2018 → Jan 2019 —
Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT03456713 Mar → Aug 2018 —
Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT03220126 Jul 2017 → Feb 2018 —
Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT03188510 Jun → Nov 2017 —
Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT03053622 Apr 2017 → Apr 2018 —
Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT02568423 Dec 2015 → Jul 2018 —
Eli Lilly and Company
Completed
No outcome recorded
Phase 1
NCT01947933 Oct 2013 → Feb 2015 psoriasis Eli Lilly and Company
Completed
No outcome recorded
Show 5 more trials Phase 2 7 trials
Phase 2
NCT07483073 May 2026 → Jun 2027 expected Crohn disease , ulcerative colitis Eli Lilly and Company
Recruiting
No outcome recorded
Phase 2
NCT07483099 May 2026 → Jun 2027 expected Crohn disease Eli Lilly and Company
Recruiting
No outcome recorded
Phase 2
NCT06598943 Oct 2024 → Dec 2027 expected ulcerative colitis Eli Lilly and Company
Recruiting
No outcome recorded
Phase 2
NCT04004611 May 2020 → Mar 2023 ulcerative colitis Eli Lilly and Company
Completed
No outcome recorded
Phase 2
NCT02891226 Dec 2016 → Dec 2018 Crohn disease Eli Lilly and Company
Completed
No outcome recorded
Phase 2
NCT02899988 Sep 2016 → Jun 2017 psoriasis Eli Lilly and Company
Completed
No outcome recorded
Phase 2
NCT02589665 Dec 2015 → Dec 2017 ulcerative colitis Eli Lilly and Company
Completed
No outcome recorded
Phase 3 14 trials
Phase 3
NCT06937099 Jun 2025 → May 2028 expected Crohn disease , obesity disorder Eli Lilly and Company
Recruiting
No outcome recorded
Phase 3
NCT05509777 Mar 2024 → Dec 2027 expected Crohn disease Eli Lilly and Company
Recruiting
No outcome recorded
Phase 3
NCT05784246 Nov 2023 → May 2026 ulcerative colitis Eli Lilly and Company
Completed
No outcome recorded
Phase 3
NCT05767021 May 2023 → Aug 2024 ulcerative colitis Eli Lilly and Company
Completed
No outcome recorded
Phase 3
NCT04844606 May 2021 → Dec 2030 expected Crohn disease , ulcerative colitis Eli Lilly and Company
Recruiting
No outcome recorded
Phase 3
NCT04469062 Apr 2021 → Mar 2024 ulcerative colitis Eli Lilly and Company
Withdrawn
No outcome recorded
Phase 3
NCT04232553 Jun 2020 → Nov 2024 overdue Crohn disease Eli Lilly and Company
Active not recruiting
No outcome recorded
Phase 3
NCT03926130 Jul 2019 → Aug 2023 Crohn disease Eli Lilly and Company
Completed
No outcome recorded
Phase 3
NCT03524092 Oct 2018 → Nov 2021 ulcerative colitis Eli Lilly and Company
Completed
No outcome recorded
Phase 3
NCT03556202 Sep 2018 → Feb 2022 psoriasis Eli Lilly and Company
Terminated
No outcome recorded
Phase 3
NCT03519945 Jul 2018 → Mar 2026 overdue ulcerative colitis Eli Lilly and Company
Active not recruiting
No outcome recorded
Phase 3
NCT03535194 Jun 2018 → Mar 2020 psoriasis Eli Lilly and Company
Completed
No outcome recorded
Phase 3
NCT03518086 Jun 2018 → Jan 2021 ulcerative colitis Eli Lilly and Company
Completed
No outcome recorded
Phase 3
NCT03482011 Apr 2018 → Mar 2019 psoriasis Eli Lilly and Company
Completed
No outcome recorded
Show 4 more trials Phase 4 7 trials
Phase 4
NCT07659353 Aug 2026 → Mar 2029 expected Crohn disease University Hospital Schleswig-Holstein
Not yet recruiting
No outcome recorded
Phase 4
NCT07612267 Jun 2026 → Sep 2028 expected inflammatory bowel disease , lactation disease Eli Lilly and Company
Not yet recruiting
No outcome recorded
Phase 4
NCT07292012 May 2026 → Nov 2027 expected Crohn disease Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Recruiting
No outcome recorded
Phase 4
NCT06997965 Apr 2026 → Sep 2027 expected Crohn disease Alimentiv Inc.
Recruiting
No outcome recorded
Phase 4
NCT07235904 Dec 2025 → Mar 2028 expected ulcerative colitis University Hospital Schleswig-Holstein
Recruiting
No outcome recorded
Phase 4
NCT06864403 Aug 2025 → Apr 2027 expected pouchitis University of North Carolina, Chapel Hill
Recruiting
No outcome recorded
Phase 4
NCT07059130 Jul 2025 → Jan 2026 overdue Crohn disease , ulcerative colitis Rubix LS
Not yet recruiting
No outcome recorded